TA
ABBV icon

TKG Advisors’s AbbVie ABBV Stock Holding History

TKG Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.59M Sell
11,916
-5
-0% -$1.11K 1.07% 36
2025
Q4 		$2.72M Sell
11,921
-713
-6% -$162K 1.1% 32
2025
Q3 		$2.93M Buy
12,634
+261
+2% +$53.1K 1.25% 26
2025
Q2 		$2.3M Buy
12,373
+561
+5% +$104K 1.03% 33
2025
Q1 		$2.47M Sell
11,812
-1,747
-13% -$340K 1.22% 28
2024
Q4 		$2.31M Buy
+13,559
New +$2.49M 1.06% 32
2024
Q1 		– Sell
-1,592
Closed -$247K – 94
2023
Q4 		$247K Sell
1,592
-4
-0.3% -$583 0.15% 87
2023
Q3 		$238K Buy
+1,596
New +$234K 0.16% 87
2023
Q2 		– Sell
-4,202
Closed -$670K – 97
2023
Q1 		$670K Buy
+4,202
New +$642K 0.42% 49

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TKG Advisors's ABBV Position: Q1 2026 in Review

TKG Advisors reduced its AbbVie (ABBV) stake by 0.04% in Q1 2026, selling an estimated $1.11K and leaving 11,916 shares worth $2.59M. The position accounts for 1.07% of the portfolio, ranked #36.

TKG Advisors first reported a position in ABBV in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.93M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • TKG Advisors held 11,916 shares of AbbVie worth $2.59M as of Q1 2026.
  • TKG Advisors sold 5 AbbVie shares in Q1 2026, an estimated $1.11K.
  • AbbVie made up 1.07% of TKG Advisors's portfolio in Q1 2026, its #36 holding.
  • TKG Advisors first reported a position in AbbVie in Q1 2023 and has held it in 9 quarters since.
  • TKG Advisors's AbbVie position peaked at $2.93M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on TKG Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.